Qpex Biopharma Is An Infectious Disease Company Focused On Developing Innovative Treatments To Combat Antimicrobial Resistanceamr Established In 2018 And Headquartered In San Diegocaliforniait Is Now A Wholly Owned Subsidiary Of Shionogi Incthe Company Aims To Improve Patient Care In Both Inpatient And Outpatient Settings By Addressing The Challenges Posed By Amr Qpex Biopharma Specializes In The Discoverydevelopmentand Regulatory Approval Of Anti Infective Medicinesits Lead Program Features Xeruborbactaman Investigational Ultra Broad Spectrum Beta Lactamase Inhibitorthe Company Collaborates With Regulatory Authorities And Academic Partners To Advance Its Research Efforts And Has Received Significant Funding From Organizations Like The Biomedical Advanced Research And Development Authoritybardato Support Its Initiativesin 2023Qpex Was Recognized For Its Contributions To The Fight Against Amr And Received Additional Funding To Enhance Its Antibiotic Portfolio
